申请人:AstraZeneca AB
公开号:US06291475B1
公开(公告)日:2001-09-18
There is provided a compound of formula I,
wherein R1, R2, R9, R10, R11, R12, X, A and B have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.
提供了一个式I的化合物,
其中R1、R2、R9、R10、R11、R12、X、A和B的含义如描述中所给,这些化合物在心律失常的预防和治疗中特别有用,尤其是房颤和室颤。